US Food and Drug Administration (FDA) on Tuesday authorized the updated vaccine Novavax against COVID-19which is designed to protect against Omicron version XBB.1.5.

FDA the statement says that authorizes the introduction of this vaccine monovalent to people over 12 years old.

Only those who have already been vaccinated against Covid-19 in the past. will need a dose of the new Novavax vaccineand those who have not yet received one injection will require two injections.

Doctor Peter Marks Director FDA Center for Biologics Evaluation and Research, stated that the updated version Novavax added to arsenal Medicines against Covid-19 available and recommended population to be vaccinated in the fall.

You might be interested in | Nobel Prize in Medicine for Kariko and Weissmann for mRNA vaccines against Covid-19

FDA too canceled starting this Tuesday permission to use original monovalent vaccine Novavax.

On September 11, he approved the use of updated vaccines against Moderna and Pfizer/BioNTechwho use lmessenger RNA method, to combat options such as Omicron HVV.1.5.

Updated vaccines Moderna and Pfizer/BioNTech approved for those over 12 years old and authorized Emergency use for people from 6 months to 11 years.

(according to information from EFE)